Evidence map›Paper›PMID 34123322›Full record

ArticleChemical science2021

Trialkylammonium salt degradation: implications for methylation and cross-coupling.

Jack B Washington, Michele Assante, Chunhui Yan, David McKinney, Vanessa Juba, Andrew G Leach, Sharon E Baillie, Marc Reid

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Jack B WashingtonWestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building 295 Cathedral Street Glasgow UK marc.reid.100@strath.ac.uk.
Michele AssanteSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University Byrom Street Liverpool UK.
Chunhui YanWestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building 295 Cathedral Street Glasgow UK marc.reid.100@strath.ac.uk.ORCID https://orcid.org/0000-0001-9921-3898
David McKinneyWestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building 295 Cathedral Street Glasgow UK marc.reid.100@strath.ac.uk.
Vanessa JubaWestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building 295 Cathedral Street Glasgow UK marc.reid.100@strath.ac.uk.
Andrew G LeachDivision of Pharmacy and Optometry, University of Manchester Stopford Building Oxford Road Manchester UK.ORCID https://orcid.org/0000-0003-1325-8273
Sharon E BaillieGlaxoSmithKline Shewalton Road Irvine North Ayrshire UK.
Marc ReidWestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building 295 Cathedral Street Glasgow UK marc.reid.100@strath.ac.uk.ORCID https://orcid.org/0000-0003-4394-3132
University of Strathclyde · GBIrvine Valley College · USLiverpool Hospital · AUUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trialkylammonium (most notably

Identifiers

PMID34123322
PMCPMC8153232
OpenAlexW3153446280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.